The stem cell transplant program in Pakistan—the first decade

Stem cell transplantation is curative in a number of otherwise fatal hematological diseases. In Pakistan, SCT was started in October 1995 at Dr Ziauddin Hospital by Dr Tahir Shamsi and his team. The first case was of a young man suffering from AML. In 1999, allogeneic BMT was started at Bismillah Ta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2008-08, Vol.42 (Suppl 1), p.S114-S117
Hauptverfasser: Shamsi, T S, Hashmi, K, Adil, S, Ahmad, P, Irfan, M, Raza, S, Masood, N, Shaikh, U, Satti, T, Farzana, T, Ansari, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S117
container_issue Suppl 1
container_start_page S114
container_title Bone marrow transplantation (Basingstoke)
container_volume 42
creator Shamsi, T S
Hashmi, K
Adil, S
Ahmad, P
Irfan, M
Raza, S
Masood, N
Shaikh, U
Satti, T
Farzana, T
Ansari, S
description Stem cell transplantation is curative in a number of otherwise fatal hematological diseases. In Pakistan, SCT was started in October 1995 at Dr Ziauddin Hospital by Dr Tahir Shamsi and his team. The first case was of a young man suffering from AML. In 1999, allogeneic BMT was started at Bismillah Taqee Institute of Health Sciences and Blood Diseases Centre, Karachi. In 2001, the Armed Forces Bone Marrow Transplant Centre, started functioning. Since then, over 350 allogeneic stem cell transplants have been carried out in these latter two centers. Another 50 autologous procedures were carried out in all centers. In 2004, a third center started transplants at the Aga Khan Hospital. The main indications for transplant are aplastic anemia, β-thalassemia major and hematological malignancies. HLA-identical sibling donors provide stem cells for the recipient. In 70% of cases, a matched donor is identified. In sharp contrast to the rest of the world, the majority of transplants are allogeneic, donor–recipient pairs are CMV positive and fungal infection, tuberculosis and malaria are particular problems. The early results are promising, with transplant-related mortality reported to be 10–20%, whereas long-term survival is reported to be 78, 72 and 49% in aplastic anemia, β-thalassemia major and leukemia, respectively. Financial constraints, poor socioeconomic status, poor transfusion services, trained human resources and difficulty in keeping pace with technological advances are major hurdles in the growth of transplant medicine. Government support is badly needed to strengthen existing facilities and to develop more centers.
doi_str_mv 10.1038/bmt.2008.137
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_815533512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A185292759</galeid><sourcerecordid>A185292759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c578t-bf9d3c24ecf1c33e79a38ea210e87d68f48b0651222187a91ee559c33b03bb253</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhS0EotPCjjWKQCobMvg_9qqqKv6kSrAoa8txbmZcEmewnQU7HoIn7JPgaEZqiworS_Z3j8-5Ogi9IHhNMFPv2jGvKcZqTVjzCK0Ib2QtmBSP0QpTqWrGpD5CxyldY0w4x-IpOiKqoZwqukJnV1uoUoaxcjAMVY42pN1gQ652cdpEO1Y-VF_td5-yDTe_fueC9z6mXHXgbAfP0JPeDgmeH84T9O3D-6uLT_Xll4-fL84vaycaleu21x1zlIPriWMMGm2ZAksJBtV0UvVctVgKQikt3qwmAELoQraYtS0V7AS92esWWz9mSNmMPi2WbYBpTkYRIRgrAoU8_S8pNRdc6kXy9V_g9TTHUFIYKnlxojBlhXr1T4pIKRvC7kht7ADGh34qi3TLv-acKEE1bYQu1PoByi5rHL2bAvS-3N8bOL0zsAU75G2ahjn7KaT74Ns96OKUUoTe7KIfbfxpCDZLS0xpiVlaYkpLCv7ykGluR-hu4UMtClDvgVSewgbibegHBf8AJdTCew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216667135</pqid></control><display><type>article</type><title>The stem cell transplant program in Pakistan—the first decade</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Shamsi, T S ; Hashmi, K ; Adil, S ; Ahmad, P ; Irfan, M ; Raza, S ; Masood, N ; Shaikh, U ; Satti, T ; Farzana, T ; Ansari, S</creator><creatorcontrib>Shamsi, T S ; Hashmi, K ; Adil, S ; Ahmad, P ; Irfan, M ; Raza, S ; Masood, N ; Shaikh, U ; Satti, T ; Farzana, T ; Ansari, S</creatorcontrib><description>Stem cell transplantation is curative in a number of otherwise fatal hematological diseases. In Pakistan, SCT was started in October 1995 at Dr Ziauddin Hospital by Dr Tahir Shamsi and his team. The first case was of a young man suffering from AML. In 1999, allogeneic BMT was started at Bismillah Taqee Institute of Health Sciences and Blood Diseases Centre, Karachi. In 2001, the Armed Forces Bone Marrow Transplant Centre, started functioning. Since then, over 350 allogeneic stem cell transplants have been carried out in these latter two centers. Another 50 autologous procedures were carried out in all centers. In 2004, a third center started transplants at the Aga Khan Hospital. The main indications for transplant are aplastic anemia, β-thalassemia major and hematological malignancies. HLA-identical sibling donors provide stem cells for the recipient. In 70% of cases, a matched donor is identified. In sharp contrast to the rest of the world, the majority of transplants are allogeneic, donor–recipient pairs are CMV positive and fungal infection, tuberculosis and malaria are particular problems. The early results are promising, with transplant-related mortality reported to be 10–20%, whereas long-term survival is reported to be 78, 72 and 49% in aplastic anemia, β-thalassemia major and leukemia, respectively. Financial constraints, poor socioeconomic status, poor transfusion services, trained human resources and difficulty in keeping pace with technological advances are major hurdles in the growth of transplant medicine. Government support is badly needed to strengthen existing facilities and to develop more centers.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/bmt.2008.137</identifier><identifier>PMID: 18724282</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Acute myeloid leukemia ; Anemia ; Aplastic anemia ; Armed forces ; Autografts ; Blood diseases ; Bone marrow ; Bone marrow transplantation ; Care and treatment ; Cell Biology ; Cytomegalovirus ; Health aspects ; Hematological diseases ; Hematology ; Hematopoietic Stem Cell Transplantation - economics ; Hematopoietic Stem Cell Transplantation - statistics &amp; numerical data ; Histocompatibility antigen HLA ; Human resources ; Humans ; Internal Medicine ; Leukemia ; Malaria ; Medicine ; Medicine &amp; Public Health ; Methods ; Military ; Mycobacterium ; Pakistan ; Public Health ; Registries ; review ; Socioeconomics ; Statistics ; Stem cell transplantation ; Stem Cells ; Thalassemia ; Transfusion ; Transplantation ; Transplantation of organs, tissues, etc ; Transplants ; Transplants &amp; implants ; Tuberculosis ; Vector-borne diseases</subject><ispartof>Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (Suppl 1), p.S114-S117</ispartof><rights>Macmillan Publishers Limited 2008</rights><rights>COPYRIGHT 2008 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Aug 2008</rights><rights>Macmillan Publishers Limited 2008.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c578t-bf9d3c24ecf1c33e79a38ea210e87d68f48b0651222187a91ee559c33b03bb253</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/bmt.2008.137$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/bmt.2008.137$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18724282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shamsi, T S</creatorcontrib><creatorcontrib>Hashmi, K</creatorcontrib><creatorcontrib>Adil, S</creatorcontrib><creatorcontrib>Ahmad, P</creatorcontrib><creatorcontrib>Irfan, M</creatorcontrib><creatorcontrib>Raza, S</creatorcontrib><creatorcontrib>Masood, N</creatorcontrib><creatorcontrib>Shaikh, U</creatorcontrib><creatorcontrib>Satti, T</creatorcontrib><creatorcontrib>Farzana, T</creatorcontrib><creatorcontrib>Ansari, S</creatorcontrib><title>The stem cell transplant program in Pakistan—the first decade</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><description>Stem cell transplantation is curative in a number of otherwise fatal hematological diseases. In Pakistan, SCT was started in October 1995 at Dr Ziauddin Hospital by Dr Tahir Shamsi and his team. The first case was of a young man suffering from AML. In 1999, allogeneic BMT was started at Bismillah Taqee Institute of Health Sciences and Blood Diseases Centre, Karachi. In 2001, the Armed Forces Bone Marrow Transplant Centre, started functioning. Since then, over 350 allogeneic stem cell transplants have been carried out in these latter two centers. Another 50 autologous procedures were carried out in all centers. In 2004, a third center started transplants at the Aga Khan Hospital. The main indications for transplant are aplastic anemia, β-thalassemia major and hematological malignancies. HLA-identical sibling donors provide stem cells for the recipient. In 70% of cases, a matched donor is identified. In sharp contrast to the rest of the world, the majority of transplants are allogeneic, donor–recipient pairs are CMV positive and fungal infection, tuberculosis and malaria are particular problems. The early results are promising, with transplant-related mortality reported to be 10–20%, whereas long-term survival is reported to be 78, 72 and 49% in aplastic anemia, β-thalassemia major and leukemia, respectively. Financial constraints, poor socioeconomic status, poor transfusion services, trained human resources and difficulty in keeping pace with technological advances are major hurdles in the growth of transplant medicine. Government support is badly needed to strengthen existing facilities and to develop more centers.</description><subject>Acute myeloid leukemia</subject><subject>Anemia</subject><subject>Aplastic anemia</subject><subject>Armed forces</subject><subject>Autografts</subject><subject>Blood diseases</subject><subject>Bone marrow</subject><subject>Bone marrow transplantation</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Cytomegalovirus</subject><subject>Health aspects</subject><subject>Hematological diseases</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation - economics</subject><subject>Hematopoietic Stem Cell Transplantation - statistics &amp; numerical data</subject><subject>Histocompatibility antigen HLA</subject><subject>Human resources</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Leukemia</subject><subject>Malaria</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Methods</subject><subject>Military</subject><subject>Mycobacterium</subject><subject>Pakistan</subject><subject>Public Health</subject><subject>Registries</subject><subject>review</subject><subject>Socioeconomics</subject><subject>Statistics</subject><subject>Stem cell transplantation</subject><subject>Stem Cells</subject><subject>Thalassemia</subject><subject>Transfusion</subject><subject>Transplantation</subject><subject>Transplantation of organs, tissues, etc</subject><subject>Transplants</subject><subject>Transplants &amp; implants</subject><subject>Tuberculosis</subject><subject>Vector-borne diseases</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9ks1u1DAUhS0EotPCjjWKQCobMvg_9qqqKv6kSrAoa8txbmZcEmewnQU7HoIn7JPgaEZqiworS_Z3j8-5Ogi9IHhNMFPv2jGvKcZqTVjzCK0Ib2QtmBSP0QpTqWrGpD5CxyldY0w4x-IpOiKqoZwqukJnV1uoUoaxcjAMVY42pN1gQ652cdpEO1Y-VF_td5-yDTe_fueC9z6mXHXgbAfP0JPeDgmeH84T9O3D-6uLT_Xll4-fL84vaycaleu21x1zlIPriWMMGm2ZAksJBtV0UvVctVgKQikt3qwmAELoQraYtS0V7AS92esWWz9mSNmMPi2WbYBpTkYRIRgrAoU8_S8pNRdc6kXy9V_g9TTHUFIYKnlxojBlhXr1T4pIKRvC7kht7ADGh34qi3TLv-acKEE1bYQu1PoByi5rHL2bAvS-3N8bOL0zsAU75G2ahjn7KaT74Ns96OKUUoTe7KIfbfxpCDZLS0xpiVlaYkpLCv7ykGluR-hu4UMtClDvgVSewgbibegHBf8AJdTCew</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Shamsi, T S</creator><creator>Hashmi, K</creator><creator>Adil, S</creator><creator>Ahmad, P</creator><creator>Irfan, M</creator><creator>Raza, S</creator><creator>Masood, N</creator><creator>Shaikh, U</creator><creator>Satti, T</creator><creator>Farzana, T</creator><creator>Ansari, S</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20080801</creationdate><title>The stem cell transplant program in Pakistan—the first decade</title><author>Shamsi, T S ; Hashmi, K ; Adil, S ; Ahmad, P ; Irfan, M ; Raza, S ; Masood, N ; Shaikh, U ; Satti, T ; Farzana, T ; Ansari, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c578t-bf9d3c24ecf1c33e79a38ea210e87d68f48b0651222187a91ee559c33b03bb253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute myeloid leukemia</topic><topic>Anemia</topic><topic>Aplastic anemia</topic><topic>Armed forces</topic><topic>Autografts</topic><topic>Blood diseases</topic><topic>Bone marrow</topic><topic>Bone marrow transplantation</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Cytomegalovirus</topic><topic>Health aspects</topic><topic>Hematological diseases</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation - economics</topic><topic>Hematopoietic Stem Cell Transplantation - statistics &amp; numerical data</topic><topic>Histocompatibility antigen HLA</topic><topic>Human resources</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Leukemia</topic><topic>Malaria</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Methods</topic><topic>Military</topic><topic>Mycobacterium</topic><topic>Pakistan</topic><topic>Public Health</topic><topic>Registries</topic><topic>review</topic><topic>Socioeconomics</topic><topic>Statistics</topic><topic>Stem cell transplantation</topic><topic>Stem Cells</topic><topic>Thalassemia</topic><topic>Transfusion</topic><topic>Transplantation</topic><topic>Transplantation of organs, tissues, etc</topic><topic>Transplants</topic><topic>Transplants &amp; implants</topic><topic>Tuberculosis</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shamsi, T S</creatorcontrib><creatorcontrib>Hashmi, K</creatorcontrib><creatorcontrib>Adil, S</creatorcontrib><creatorcontrib>Ahmad, P</creatorcontrib><creatorcontrib>Irfan, M</creatorcontrib><creatorcontrib>Raza, S</creatorcontrib><creatorcontrib>Masood, N</creatorcontrib><creatorcontrib>Shaikh, U</creatorcontrib><creatorcontrib>Satti, T</creatorcontrib><creatorcontrib>Farzana, T</creatorcontrib><creatorcontrib>Ansari, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shamsi, T S</au><au>Hashmi, K</au><au>Adil, S</au><au>Ahmad, P</au><au>Irfan, M</au><au>Raza, S</au><au>Masood, N</au><au>Shaikh, U</au><au>Satti, T</au><au>Farzana, T</au><au>Ansari, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The stem cell transplant program in Pakistan—the first decade</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>42</volume><issue>Suppl 1</issue><spage>S114</spage><epage>S117</epage><pages>S114-S117</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><abstract>Stem cell transplantation is curative in a number of otherwise fatal hematological diseases. In Pakistan, SCT was started in October 1995 at Dr Ziauddin Hospital by Dr Tahir Shamsi and his team. The first case was of a young man suffering from AML. In 1999, allogeneic BMT was started at Bismillah Taqee Institute of Health Sciences and Blood Diseases Centre, Karachi. In 2001, the Armed Forces Bone Marrow Transplant Centre, started functioning. Since then, over 350 allogeneic stem cell transplants have been carried out in these latter two centers. Another 50 autologous procedures were carried out in all centers. In 2004, a third center started transplants at the Aga Khan Hospital. The main indications for transplant are aplastic anemia, β-thalassemia major and hematological malignancies. HLA-identical sibling donors provide stem cells for the recipient. In 70% of cases, a matched donor is identified. In sharp contrast to the rest of the world, the majority of transplants are allogeneic, donor–recipient pairs are CMV positive and fungal infection, tuberculosis and malaria are particular problems. The early results are promising, with transplant-related mortality reported to be 10–20%, whereas long-term survival is reported to be 78, 72 and 49% in aplastic anemia, β-thalassemia major and leukemia, respectively. Financial constraints, poor socioeconomic status, poor transfusion services, trained human resources and difficulty in keeping pace with technological advances are major hurdles in the growth of transplant medicine. Government support is badly needed to strengthen existing facilities and to develop more centers.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>18724282</pmid><doi>10.1038/bmt.2008.137</doi></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (Suppl 1), p.S114-S117
issn 0268-3369
1476-5365
language eng
recordid cdi_proquest_miscellaneous_815533512
source MEDLINE; SpringerLink Journals; Nature Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Acute myeloid leukemia
Anemia
Aplastic anemia
Armed forces
Autografts
Blood diseases
Bone marrow
Bone marrow transplantation
Care and treatment
Cell Biology
Cytomegalovirus
Health aspects
Hematological diseases
Hematology
Hematopoietic Stem Cell Transplantation - economics
Hematopoietic Stem Cell Transplantation - statistics & numerical data
Histocompatibility antigen HLA
Human resources
Humans
Internal Medicine
Leukemia
Malaria
Medicine
Medicine & Public Health
Methods
Military
Mycobacterium
Pakistan
Public Health
Registries
review
Socioeconomics
Statistics
Stem cell transplantation
Stem Cells
Thalassemia
Transfusion
Transplantation
Transplantation of organs, tissues, etc
Transplants
Transplants & implants
Tuberculosis
Vector-borne diseases
title The stem cell transplant program in Pakistan—the first decade
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20stem%20cell%20transplant%20program%20in%20Pakistan%E2%80%94the%20first%20decade&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Shamsi,%20T%20S&rft.date=2008-08-01&rft.volume=42&rft.issue=Suppl%201&rft.spage=S114&rft.epage=S117&rft.pages=S114-S117&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/bmt.2008.137&rft_dat=%3Cgale_proqu%3EA185292759%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216667135&rft_id=info:pmid/18724282&rft_galeid=A185292759&rfr_iscdi=true